Related references
Note: Only part of the references are listed.Quercetin, Epigallocatechin Gallate, Curcumin, and Resveratrol: From Dietary Sources to Human MicroRNA Modulation
Erika Cione et al.
MOLECULES (2020)
Sustained Cerebrovascular and Cognitive Benefits of Resveratrol in Postmenopausal Women
Jay Jay Thaung Zaw et al.
NUTRIENTS (2020)
No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial
Marlies de Ligt et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2020)
Resveratrol for adults with type 2 diabetes mellitus
Maya M. Jeyaraman et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial
A. Sattarinezhad et al.
DIABETES & METABOLISM (2019)
Rs12778366 single nucleotide polymorphism of Sirtuin 1 (SIRT1) and response to resveratrol supplementation in patients with type 2 diabetes mellitus
Roberto Gambino et al.
ACTA DIABETOLOGICA (2019)
The Effect of Resveratrol Supplementation on Cardio-Metabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized, Double-Blind Controlled Trial
Shima Abdollahi et al.
PHYTOTHERAPY RESEARCH (2019)
Health benefits of resveratrol administration
Sabina Galiniak et al.
ACTA BIOCHIMICA POLONICA (2019)
The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease
Asma Hoseini et al.
FOOD & FUNCTION (2019)
Effect of low-ratio n-6/n-3 PUFA on blood glucose: a meta-analysis
Na Li et al.
FOOD & FUNCTION (2019)
The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
ShadiSadat Seyyedebrahimi et al.
ACTA DIABETOLOGICA (2018)
Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial
Konstantinos Kantartzis et al.
DIABETES OBESITY & METABOLISM (2018)
Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
Somayyeh Asghari et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2018)
Resveratrol supplementation decreases blood glucose without changing the circulating CD14+ CD16+ monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
Hadi Khodabandehloo et al.
NUTRITION RESEARCH (2018)
Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes
Marlies de Ligt et al.
MOLECULAR METABOLISM (2018)
Health Effects of Resveratrol: Results from Human Intervention Trials
Sonia L. Ramirez-Garza et al.
NUTRIENTS (2018)
Resveratrol: A miraculous natural compound for diseases treatment
Mehdi Koushki et al.
FOOD SCIENCE & NUTRITION (2018)
Effects of resveratrol supplementation on risk factors of non-communicable diseases: A meta-analysis of randomized controlled trials
Xiao-Fei Guo et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2018)
The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis
Ahmad Zare Javid et al.
PHYTOTHERAPY RESEARCH (2017)
No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial
Thomas Nordstrom Kjaer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Resveratrol Improves Vascular Function and Mitochondrial Number but Not Glucose Metabolism in Older Adults
Rena M. Pollack et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2017)
Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis
Xiangyun Zhu et al.
NUTRITION & METABOLISM (2017)
A comprehensive review of the health perspectives of resveratrol
Abdur Rauf et al.
FOOD & FUNCTION (2017)
The therapeutic potential of resveratrol: a review of clinical trials
Adi Y. Berman et al.
NPJ PRECISION ONCOLOGY (2017)
Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial
Sony S. Thazhath et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial
Silvie Timmers et al.
DIABETES CARE (2016)
Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions
Kerry J. Welsh et al.
DIABETES CARE (2016)
Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial
Beata Banaszewska et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
SIRT1 and insulin resistance
Yue Cao et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial
S. Bo et al.
PHARMACOLOGICAL RESEARCH (2016)
Prevalence and prevention of cardiovascular disease and diabetes mellitus
Pitchai Balakumar et al.
PHARMACOLOGICAL RESEARCH (2016)
Antidiabetic Effects of Resveratrol: The Way Forward in Its Clinical Utility
Omolola R. Oyenihi et al.
JOURNAL OF DIABETES RESEARCH (2016)
Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms
Robert G. Britton et al.
RESVERATROL AND HEALTH (2015)
The molecular targets of resveratrol
Sameer S. Kulkarni et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
Forouzan Faghihzadeh et al.
BRITISH JOURNAL OF NUTRITION (2015)
Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
Shihui Chen et al.
DIGESTIVE AND LIVER DISEASE (2015)
Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans
J. Gambini et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus-systematic review and meta-analysis
Heather A. Hausenblas et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2015)
Resveratrol Does Not Influence Metabolic Risk Markers Related to Cardiovascular Health in Overweight and Slightly Obese Subjects: A Randomized, Placebo-Controlled Crossover Trial
Sanne M. van der Made et al.
PLOS ONE (2015)
Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis:of 11 randomized controlled trials
Kai Liu et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
Obesity, Diabetes, and the Metabolic Syndrome: The Global Scourge
Raj S. Padwal
CANADIAN JOURNAL OF CARDIOLOGY (2014)
Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
Veronique S. Chachay et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Effects of Resveratrol in Patients With Type 2 Diabetes Mellitus on Skeletal Muscle SIRT1 Expression and Energy Expenditure
Kian Peng Goh et al.
INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM (2014)
Effects of Resveratrol on Memory Performance, Hippocampal Functional Connectivity, and Glucose Metabolism in Healthy Older Adults
A. Veronica Witte et al.
JOURNAL OF NEUROSCIENCE (2014)
Contribution of six risk factors to achieving the 25x25 non-communicable disease mortality reduction target: a modelling study
Vasilis Kontis et al.
LANCET (2014)
Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
Miriam Mendez-del Villar et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2014)
High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men
Satya Dash et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Anti-Inflammatory and Antioxidant Effects of Resveratrol in Healthy Smokers A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial
S. Bo et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Joao Tomé-Carneiro et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
High-Dose Resveratrol Supplementation in Obese Men An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
Morten M. Poulsen et al.
DIABETES (2013)
Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients
Ali Movahed et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
Nathan L. Price et al.
CELL METABOLISM (2012)
Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance
Jill P. Crandall et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2012)
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Jayesh Kumar Bhatt et al.
NUTRITION RESEARCH (2012)
Resveratrol: French paradox revisited
Betul Catalgol et al.
FRONTIERS IN PHARMACOLOGY (2012)
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
Pal Brasnyo et al.
BRITISH JOURNAL OF NUTRITION (2011)
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
Silvie Timmers et al.
CELL METABOLISM (2011)
Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment
Keisuke Fujitaka et al.
NUTRITION RESEARCH (2011)
Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase
Chih-Chun Chang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2011)
Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
Ketan R. Patel et al.
CANCER RESEARCH (2010)
DOSE-DEPENDENCY OF RESVERATROL IN PROVIDING HEALTH BENEFITS
Subhendu Mukherjee et al.
DOSE-RESPONSE (2010)
Resveratrol commonly displays hormesis: Occurrence and biomedical significance
Edward J. Calabrese et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2010)
Surrogate markers of insulin resistance: A review
Bhawna Singh et al.
WORLD JOURNAL OF DIABETES (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Age-associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice
Kathryn Moynihan Ramsey et al.
AGING CELL (2008)
Resveratrol - A multitargeted agent for age-associated chronic diseases
Kuzhuvelil B. Harikumar et al.
CELL CYCLE (2008)
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
David J. Boocock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α
Marie Lagouge et al.
CELL (2006)
High absorption but very low bioavailability of oral resveratrol in humans
T Walle et al.
DRUG METABOLISM AND DISPOSITION (2004)
The daily oral administration, of high doses of trans-resveratrol to rats for 28 days is not harmful
ME Juan et al.
JOURNAL OF NUTRITION (2002)
Share Paper
